Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
The eligibility criteria provided appear to contain a formatting error — the inclusion and exclusion criteria listed are identical, which suggests the source document may have a transcription or copy-paste error. The true exclusion criteria cannot be reliably determined from the information provided.
Below is a plain-English summary based only on what is clearly stated, with a note where confirmation is needed.
Who might be able to join this trial:
- People who have been recommended for a stem cell transplant using a donor (called an allogeneic transplant)
- People whose available donor is not a perfect 10/10 match across five specific genetic markers (HLA-A, HLA-B, HLA-Cw, HLA-DRB1, and HLA-DQB1)
- People whose transplant would use stem cells collected from the blood or from bone marrow
- People diagnosed with one of the following blood or bone marrow conditions: acute myeloid leukaemia, chronic myeloid leukaemia (Ph+), myelodysplastic syndromes, or myeloproliferative neoplasms
- People whose disease is considered high-risk, such as having more than 5% abnormal cells remaining after treatment, having certain chromosome changes (such as loss of chromosome 7 or a complex karyotype), having a p53 gene mutation, having treatment-related myelodysplastic syndrome, undergoing a second or later donor transplant after relapse, or having chronic myelomonocytic leukaemia or unclassifiable myeloproliferative neoplasms
- People who do not have a serious unrelated illness at the time of joining
Who may not be able to join:
- The exclusion criteria in the source document appear to be identical to the inclusion criteria, which suggests a possible error in the original document (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +78123386265
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival analysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.